Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.
about
Omega-3 fatty acids and major depression: a primer for the mental health professionalOxidation of marine omega-3 supplements and human healthLifestyle-related factors in predementia and dementia syndromesOmega 3 fatty acids for prevention and treatment of cardiovascular diseaseRisks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic reviewEffects of some common food constituents on cardiovascular diseaseCanadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trialsResolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signalsEffects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot studyEpidemiology of coronary heart disease and acute coronary syndromeDiabetes DyslipidemiaAnti-Inflammatory Diet for Atherosclerosis and Coronary Artery Disease: Antioxidant FoodsTreatment of dyslipidemiaOmega-3s and cardiovascular health.Dietary intake of total marine n-3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid and the risk of acute coronary syndrome - a cohort study.Omega-3 Fatty Acids and Cardiovascular Disease: Are There Benefits?Beneficial effects of omega-3 polyunsaturated Fatty acids in gestational diabetes: consequences in macrosomia and adulthood obesitySubdural hematoma after a fall in an elderly patient taking high-dose omega-3 fatty acids with warfarin and aspirin: case report and review of the literatureA review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levelsDietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathwayA review of the biologic and pharmacologic role of docosapentaenoic acid n-3Redox-dependent anti-inflammatory signaling actions of unsaturated fatty acidsProtectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomeDetection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl estersEffect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in patients with a previous myocardial infarction: a randomised controlled trialResolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets.Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution.Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.Red blood cell docosahexaenoic acid and eicosapentaenoic acid concentrations are positively associated with socioeconomic status in patients with established coronary artery disease: data from the Heart and Soul StudyDietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model.Secondary prevention of heart disease--knowledge among cardiologists and omega-3 (omega-3) fatty acid prescribing behaviors in Karachi, Pakistan.Association between omega-3 fatty acids and depressive symptoms among patients with established coronary artery disease: data from the Heart and Soul Study.Red blood cell fatty acid patterns and acute coronary syndrome.New data on the clinical impact of exercise training, fish oils, and statins in heart failure.Long-term fish oil supplementation induces cardiac electrical remodeling by changing channel protein expression in the rabbit model.Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials.Triglycerides and HDL cholesterol: stars or second leads in diabetes?Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease.Natural Products in Epilepsy-the Present Situation and Perspectives for the Future.Simultaneous quantification of total eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid in plasma by high-performance liquid chromatography-tandem mass spectrometry.
P2860
Q21245686-66F9C12B-C421-44FD-87AA-9500C698DF77Q21284850-AACBD53F-C301-4C56-9280-DE2720EA8240Q22241490-9B888D2F-EDBE-439D-B71C-D94CFA59C06BQ24245810-8BFC55FC-C61C-4D4E-A0E3-9FB3435AAE97Q24541608-79100585-FF0A-400B-A432-65128FB3FF17Q24605384-F82D56B0-7896-400B-B50B-592AD63D464BQ24650348-A072733F-742C-45B3-82F9-C33A3C74118DQ24673096-C647FF04-5465-46E5-B700-7119F5F8FE3BQ24793945-20522D27-BBDA-47E9-9099-3F21B718EE21Q26738525-53034E7C-B5C7-4007-9946-FADA3F962471Q26750905-EF9FE58F-8D56-4A93-AF7C-7438CD91821BQ26798027-243C1BDF-4C55-4829-BA0E-6045F992FBEFQ27026114-0385F49E-3546-48A4-9F10-74BA5B5BC7B4Q27686781-55CAFE6F-8FC4-4280-8C80-87C67ED677B3Q27863412-2427FB75-B1E3-416A-BF3B-D31EDD78AA45Q28069946-BB9ED37A-3EB5-444D-BF65-FB768397B4A8Q28084681-2B42AA9C-926C-4A81-A81E-3DE5D60D7A5FQ28213487-15EDFB52-FA5F-4054-82E3-6EDD0A2A2904Q28219488-49DB4A21-2AEE-414B-9CD5-B36CFCC85BAAQ28235974-E1E79218-08B5-4AA1-81EA-FEEDDB040325Q28248251-CD4FCD9D-96C7-4734-BD14-F65D9834B577Q28386488-EE9CD6A1-E1E8-4202-B9B8-3733855D7A74Q28387661-811F9ED4-DA33-43F0-B6DD-AF79DDBE0DEBQ28397031-B26981BB-6544-468F-AAD8-615E8AF060C1Q28677739-A83EDB8E-A2D5-4D00-BC34-7B8D84277278Q30482801-DA7DD7FA-0EA7-4E9A-B3C7-EDB28EFF5EFDQ30486807-22A4658F-EC22-4BCD-A8AA-308B374A9B56Q31134484-EFA77A24-6109-416C-98F3-EC85C9092884Q31156096-90B663D6-B326-4CFA-BBA0-9E2EDCA34850Q33227649-FFDB4E43-1BB9-4893-8384-8E728DDF77D1Q33403376-EED87254-6FE1-4747-8A76-C5ECE23D24BDQ33410066-6E830F53-A50B-45CF-B2D8-8C572FD22A96Q33440563-81FE395B-2135-4FA8-ADC7-C3A08A5EC0B7Q33521834-9B0D44DB-D9DE-475B-B722-92E605209EB0Q33559941-28D9817F-DB62-4987-97AF-A711A472BFC1Q33594958-F4A23EDD-EE7B-4177-8BC9-FA563DA4F696Q33610637-0C0DCA58-4C86-4049-8FDC-7725644C72C1Q33641823-4532CAAE-E1AF-4D3E-A254-F465CCBA26F8Q33664290-FDF558D5-F5DF-4186-8614-02530F320537Q33671935-C6DC1183-0BEF-472B-B665-FF050C5EC776
P2860
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Early protection against sudde ...... iocardico (GISSI)-Prevenzione.
@ast
Early protection against sudde ...... iocardico (GISSI)-Prevenzione.
@en
type
label
Early protection against sudde ...... iocardico (GISSI)-Prevenzione.
@ast
Early protection against sudde ...... iocardico (GISSI)-Prevenzione.
@en
prefLabel
Early protection against sudde ...... iocardico (GISSI)-Prevenzione.
@ast
Early protection against sudde ...... iocardico (GISSI)-Prevenzione.
@en
P2093
P1433
P1476
Early protection against sudde ...... iocardico (GISSI)-Prevenzione.
@en
P2093
Carlo Schweiger
Carmine Chieffo
Corrado Tucci
Domenico Di Gregorio
Elena Bomba
Enrico Geraci
Federica Barzi
Franco Valagussa
G Mastrogiuseppe
GISSI-Prevenzione Investigators
P304
P356
10.1161/01.CIR.0000014682.14181.F2
P407
P577
2002-04-01T00:00:00Z